Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07513363

The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency

The Role of Urinary RhoA, NGF, and BDNF Levels in Diagnosis and Follow-up in Children With Overactive Bladder and Vitamin D Deficiency.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
Tarik Emre Sener · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The primary aim of this study is to evaluate the role of three specific urinary proteins-RhoA, Nerve Growth Factor (NGF), and Brain-Derived Neurotrophic Factor (BDNF)-as potential biomarkers for the diagnosis and follow-up of children aged 4-18 diagnosed with Overactive Bladder (OAB) and Vitamin D deficiency.

Conditions

Interventions

TypeNameDescription
BEHAVIORALUrotherapyDiagnosis and first-line treatment (urotherapy) will be conducted per European Association of Urology (EAU) guidelines.

Timeline

Start date
2026-05-01
Primary completion
2026-12-01
Completion
2027-01-01
First posted
2026-04-07
Last updated
2026-04-07

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07513363. Inclusion in this directory is not an endorsement.

The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency (NCT07513363) · Clinical Trials Directory